A, H., A, A., A, H., G, R., A, Z. A., J, R., . . . C, T. (2025). Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: A meta-analysis and systematic review. Therapeutic advances in neurological disorders, 18, 17562864251343574. https://doi.org/10.1177/17562864251343574
Chicago Style (17th ed.) CitationA, Hammed, et al. "Efficacy and Safety of Combining Re-irradiation with Bevacizumab Compared to Bevacizumab Alone in the Management of Recurrent High-grade Gliomas: A Meta-analysis and Systematic Review." Therapeutic Advances in Neurological Disorders 18 (2025): 17562864251343574. https://doi.org/10.1177/17562864251343574.
MLA (9th ed.) CitationA, Hammed, et al. "Efficacy and Safety of Combining Re-irradiation with Bevacizumab Compared to Bevacizumab Alone in the Management of Recurrent High-grade Gliomas: A Meta-analysis and Systematic Review." Therapeutic Advances in Neurological Disorders, vol. 18, 2025, p. 17562864251343574, https://doi.org/10.1177/17562864251343574.
